Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes.
Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes.
复制标题
DOI:
10.1155/2016/8317850
复制
发表时间:
2016
影响因子:
4.3
通讯作者:
Grineva EN
中科院分区:
文献类型:
--
作者:
Bayrasheva VK;Babenko AY;Dobronravov VA;Dmitriev YV;Chefu SG;Pchelin IY;Ivanova AN;Bairamov AA;Alexeyeva NP;Shatalov IS;Grineva EN
Type 2 diabetes (DM2) could be reproduced in rats with alimentary obesity by using low doses of streptozotocin (LD-STZ) as well as STZ in high doses with preliminary nicotinamide (NA) administration. However, STZ could induce tubulotoxicity. Aim. To develop rat model of DN in NA-STZ-induced DM2 and compare it with LD-STZ-model in order to choose the most relevant approach for reproducing renal glomerular and tubular morphofunctional diabetic changes. Starting at 3 weeks after uninephrectomy, adult male Wistar rats were fed five-week high-fat diet and then received intraperitoneally either LD-STZ (40 mg/kg) or NA (230 mg/kg) followed by STZ (65 mg/kg). Control uninephrectomized vehicle-injected rats received normal chow. At weeks 10, 20, and 30 (the end of the study), metabolic parameters, creatinine clearance, albuminuria, and urinary tubular injury markers (NGAL, KIM-1) were evaluated as well as renal ultrastructural and light microscopic changes at weeks 20 and 30. NA-STZ-group showed higher reproducibility and stability of metabolic parameters. By week 10, in NA-STZ-group NGAL level was significantly lower compared to LD-STZ-group. By week 30, diabetic groups showed early features of DN. However, morphofunctional changes in NA-STZ-group appeared to be more pronounced than those in STZ-group despite lower levels of KIM-1 and NGAL. We proposed a new rat model of DM2 with DN characterized by stable metabolic disorders, typical renal lesions, and lower levels of tubular injury markers as compared to LD-STZ-induced diabetes.
登录
查看更多内容
影响因子:
3.7
作者:
Nakagawa S;Nishihara K;Miyata H;Shinke H;Tomita E;Kajiwara M;Matsubara T;Iehara N;Igarashi Y;Yamada H;Fukatsu A;Yanagita M;Matsubara K;Masuda S
通讯作者:
Masuda S
影响因子:
2.2
作者:
Khan E;Batuman V;Lertora JJ
通讯作者:
Lertora JJ
DOI:
10.1111/j.1751-7176.2011.00434.x
发表时间:
2011-04
期刊:
Journal of clinical hypertension (Greenwich, Conn.)
影响因子:
--
作者:
Long AN;Dagogo-Jack S
通讯作者:
Dagogo-Jack S
DOI:
10.1155/2012/140103
发表时间:
2012
期刊:
Evidence-based complementary and alternative medicine : eCAM
影响因子:
--
作者:
Liu IM;Tzeng TF;Liou SS;Chang CJ
通讯作者:
Chang CJ
影响因子:
2.8
作者:
de Carvalho, Jose Antonio M.;Tatsch, Etiane;Moresco, Rafael N.
通讯作者:
Moresco, Rafael N.